GENEO ENTERPRISES LIMITED

Active Lancaster

Activities of head offices

0 employees website.com
Activities of head offices
G

GENEO ENTERPRISES LIMITED

Activities of head offices

Founded 18 Nov 2009 Active Lancaster, United Kingdom 0 employees website.com
Activities of head offices
Accounts Submitted 21 Aug 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 9 Dec 2025 Next due 2 Dec 2026 6 months remaining
Net assets £51K £55K 2024 year on year
Total assets £51K £51K 2024 year on year
Total Liabilities £0 £4K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Dalton House 9 Dalton Square Lancaster LA1 1WD

Full company profile for GENEO ENTERPRISES LIMITED (07080715), an active company based in Lancaster, United Kingdom. Incorporated 18 Nov 2009. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£51.35k

Increased by £54.94k (+1532%)

Total Liabilities

N/A

Decreased by £3.92k (-100%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 1194 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Steven Paul ReekieDirectorBritishEngland6015 Mar 2012Active
Timothy James KingDirectorBritishUnited Kingdom608 Feb 2010Active

Shareholders

Shareholders (3)

Timothy James King
47.0%
47
Mark David Radley
47.0%
47

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Mark David Radley

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB March 1966
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Timothy James King

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB September 1965
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

GENEO ENTERPRISES LIMITED Current Company
LITTLE CICERO LIMITED united kingdom
GENEO SOFTWARE LIMITED united kingdom
GENEO HOMES LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Dec 2025Confirmation StatementConfirmation statement made on 18 Nov 2025 with updates
20 Nov 2025OfficersChange to director Mr Steven Paul Reekie on 20 Nov 2025
20 Nov 2025OfficersChange to director Timothy James King on 20 Nov 2025
7 Oct 2025CapitalCapital Name Of Class Of Shares
2 Oct 2025IncorporationMemorandum Articles
9 Dec 2025 Confirmation Statement

Confirmation statement made on 18 Nov 2025 with updates

20 Nov 2025 Officers

Change to director Mr Steven Paul Reekie on 20 Nov 2025

20 Nov 2025 Officers

Change to director Timothy James King on 20 Nov 2025

7 Oct 2025 Capital

Capital Name Of Class Of Shares

2 Oct 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 18 Nov 2025 with updates

5 months ago on 9 Dec 2025

Change to director Mr Steven Paul Reekie on 20 Nov 2025

5 months ago on 20 Nov 2025

Change to director Timothy James King on 20 Nov 2025

5 months ago on 20 Nov 2025

Capital Name Of Class Of Shares

7 months ago on 7 Oct 2025

Memorandum Articles

7 months ago on 2 Oct 2025